Cargando…
Establishment and External Validation of a Hypoxia-Derived Gene Signature for Robustly Predicting Prognosis and Therapeutic Responses in Glioblastoma Multiforme
OBJECTIVE: Hypoxia presents a salient feature investigated in most solid tumors that holds key roles in cancer progression, including glioblastoma multiforme (GBM). Here, we aimed to construct a hypoxia-derived gene signature for identifying the high-risk GBM patients to guide adjuvant therapy and p...
Autores principales: | Wang, Ke, Lu, Yang, Liu, Zhihong, Diao, Min, Yang, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837434/ https://www.ncbi.nlm.nih.gov/pubmed/35155681 http://dx.doi.org/10.1155/2022/7858477 |
Ejemplares similares
-
Glioblastoma multiforme: Effect of hypoxia and hypoxia inducible factors on therapeutic approaches
por: Huang, Wen-Juan, et al.
Publicado: (2016) -
Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme
por: Yu, Ziye, et al.
Publicado: (2022) -
Network Signatures of Survival in Glioblastoma Multiforme
por: Patel, Vishal N., et al.
Publicado: (2013) -
An Integrated mRNA and microRNA Expression Signature for Glioblastoma Multiforme Prognosis
por: Xiong, Jie, et al.
Publicado: (2014) -
Identification of T‐cell exhaustion‐related gene signature for predicting prognosis in glioblastoma multiforme
por: Liu, Yue‐hui, et al.
Publicado: (2023)